Stock-Based Compensation (Details) - $ / shares |
3 Months Ended | 12 Months Ended | |||
---|---|---|---|---|---|
Mar. 31, 2022 |
Mar. 31, 2021 |
Dec. 31, 2021 |
Dec. 31, 2020 |
Nov. 30, 2021 |
|
Stock-Based Compensation (Details) [Line Items] | |||||
Option awards, description | Option awards are generally granted with an exercise price equal to the fair value of the Company’s stock at the date of grant; those options generally vest based on four years of continuous service and have 10-year contractual terms. | ||||
Weighted-average grant-date fair value of options (in Dollars per share) | $ 4.06 | $ 0 | $ 4.19 | $ 0 | |
Weighted-average remaining contractual term | 10 years | 0 years | |||
Description of option awards | Option awards are generally granted with an exercise price equal to the fair value of the Company’s stock at the date of grant; those options generally vest based on four years of continuous service and have 10-year contractual terms. | ||||
Weighted average remaining contractual term for the outstanding options | 10 years | 0 years | |||
2021 Plan [Member] | |||||
Stock-Based Compensation (Details) [Line Items] | |||||
Number of shares of common stock available for issuance (in Shares) | 942,068 | ||||
Number of shares of common stock (in Shares) | 1,250,432 | ||||
Restricted Stock [Member] | |||||
Stock-Based Compensation (Details) [Line Items] | |||||
Weighted-average remaining contractual term | 10 years | 10 years |
X | ||||||||||
- Definition Description of option awards. No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Weighted average remaining contractual term for the outstanding options. No definition available.
|
X | ||||||||||
- Definition Shares contributed to the ESOP that have not yet been released, committed to be released, or allocated to participant accounts. Suspense shares generally collateralize ESOP debt. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Description of terms of share-based payment arrangement. Includes, but is not limited to, type of award or grantee and reason for issuance. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Weighted average grant-date fair value of options vested. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|